在患有高血压的患者中,左心室腹腔功能障碍的参数与伴随的2型糖尿病的疾病
Olexandr Bilovol1, Iryna Knyazkova1, Inna Dunaieva1
1KHARKIV NATIONAL MEDICAL UNIVERSITY, KHARKIV, UKRAINE.
概括
这项研究研究了eplerenone和trimetazidine如何影响高血压和2型糖尿病患者的左心室透静功能. 治疗改善了心肌放松,并减少了心力衰竭的进展和心血管风险.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 高血压 (HT) 和2型糖尿病 (T2DM) 是心血管疾病的重要危险因素.
- 扩张性功能障碍是并发性HT和T2DM患者的常见并发症.
- 了解特定药理干预措施对透缩功能的影响对于管理这些患者至关重要.
研究的目的:
- 评估HT患者的左心室 (LV) 扩张功能参数,有或没有T2DM.
- 评估3个月的Eplerenone (50毫克/天) 和Trimetazidine (80毫克/天) 联合治疗方案对LV透缩功能的影响.
- 为了比较单独患有HT的患者和同时患有HT和T2DM的患者之间的结果.
主要方法:
- 一项涉及50名II期HT患者 (45-54岁) 的研究,分为两组:仅HT (n=25) 和HT与T2DM (n=25).
- 为了进行比较,包括了20名健康个体的对照组.
- 患者接受了3个月的eplerenone和trimetazidine疗程;治疗前和治疗后分析了LV静脉动静脉功能参数,包括左心房体积指数 (LAVI).
主要成果:
- 初步分析显示,与单独的HT和对照组相比,HT和T2DM患者的左心房体积指数 (LAVI) 较高,这表明逐渐的功能变化.
- 这些变化归因于心肌细胞动力学变化,由伴随病理病理的代谢和血液动力学障碍驱动.
- 虽然在基线时差异没有统计学意义,但趋势表明T2DM组的负担更大.
结论:
- 在这两组患者中,用eplerenone和trimetazidine进行为期三个月的治疗似乎可以增强心肌梗塞在腹痛期间的放松.
- 综合疗法在降低心力衰竭进展率方面表现出积极的影响.
- 这种治疗方案有助于显著降低HT和T2DM患者的整体心血管风险.
相关概念视频
Heart Failure II: Pathophysiology
15
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
15
Hypertension I: Introduction
16
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
16
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure III: Clinical Manifestations
23
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
23
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16


